#weight-loss medications
2 stories
The risky boom in cut-price weight-loss drugs
Compounding pharmacies are flooding the market with cheaper versions of GLP-1 drugs, but with far less oversight than brand-name alternatives.
TIME · 3m
Push for subsidised weight-loss drugs for PMOS
Australian advocates want GLP-1 medications funded on the PBS for women with polyendrocrine metabolic ovarian syndrome, but approval remains uncertain.
the Guardian · 1m